Fenofibrate Tablet
Product Images NDC 33342-347

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 33342-347). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fenofibrate-160-10x10-baddi-cart (Fenofibrate 160 10x10 Baddi Cart)

This is a description of Macleods Pharma USA's Fenofibrate Tablets USP, with each tablet containing 160 mg of the active ingredient. The batch number and expiration date are mentioned. The tablets are manufactured by Macleods Pharmaceuticals Ltd. in India. The packaging includes 100 tablets in a unit-dose format. It is recommended to store the tablets at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The package is not child-resistant, so it should be kept out of reach of children. Additional prescribing information is available in the accompanying insert.*

FDA Label Image

Fenofibrate-160-10x10-daman-cart (Fenofibrate 160 10x10 Daman Cart)

This is a description of Macleody Pharma USA's product: Fenofibrate Tablets, USP 160 mg per tablet. Each tablet is film-coated and packaged in blister packs containing 100 tablets (10 x 10 unit-dose). The batch number and expiration date are included on the packaging. The manufacturing location is specified as Macleods Pharmaceuticals Ltd in Daman, India. The product should be stored at 20°C to 25°C and protected from moisture. The packaging also includes safety instructions to keep the medication out of reach of children as the unit-dose package is not child-resistant. Complete prescribing information should be consulted before use.*

FDA Label Image

Fenofibrate-160-500-cont-baddi (Fenofibrate 160 500 Cont Baddi)

This is a description of a medication container for Fenofibrate 160 mg tablets. It provides information on storage conditions, manufacturer details, NDC code, and precautions about the safety seal. The container should be tightly-closed, stored at 20° to 25°C, and protected from moisture. The text includes details on the manufacturer, Macleods Pharma USA, Inc., and Macleods Pharmaceuticals Ltd. It also emphasizes the importance of keeping the medicine out of reach of children.*

FDA Label Image

Fenofibrate-160-500-cont-daman (Fenofibrate 160 500 Cont Daman)

This text provides detailed information about a medication containing Fenofibrate USP in a child-resistant container with film-coated tablets of 160 mg each. The medication should be stored in a tightly-closed container at a temperature between 20°C to 25°C and protected from moisture. The text also mentions the manufacturer details and emphasizes keeping the medication out of reach of children.*

FDA Label Image

Fenofibrate-160-90-cont-baddi (Fenofibrate 160 90 Cont Baddi)

This is a description of Fenofibrate tablets, USP 160 mg manufactured by Macleods Pharma USA, Inc. It is advised to dispense in a tightly-closed, light-resistant container with a child-resistant closure. The tablets should be stored at 20° to 25°C (68° to 77°F) with excursions allowed to 15° to 30°C (59° to 86°F). Protection from moisture is essential. The package contains 90 film-coated tablets and should not be used if the safety seal is broken. This medication information provides details about prescribing and usage, and it is essential to keep all medications out of reach of children.*

FDA Label Image

Fenofibrate-160-90-cont-daman (Fenofibrate 160 90 Cont Daman)

This text is a label for Fenofibrate tablets, USP, with a strength of 160 mg. It includes information like manufacturer details, storage instructions, and a warning not to use if the safety seal is broken. The tablets are meant to be dispensed in a tightly-closed, light-resistant container with child-resistant closure. For complete prescribing information, the accompanying insert should be consulted. The recommended storage temperature is 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F).*

FDA Label Image

Fenofibrate-54-10x10-baddi-cart (Fenofibrate 54 10x10 Baddi Cart)

This is information for Fenofibrate tablets, USP, containing 54 mg per tablet. The package includes 100 tablets (10x 10 unit dose) manufactured by Madeods Pharmaceuticals Ltd in Badd, Himachal Pradesh, India. The tablets are to be stored at a temperature of 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). For complete prescribing information, refer to the accompanying insert. Remember to keep this and all medication out of the reach of children.*

FDA Label Image

Fenofibrate-54-90-cont-baddi (Fenofibrate 54 90 Cont Baddi)

This is a description of Fenofibrate tablets, USP, containing 54 mg of Fenofibrate each. The tablets are packaged in a bottle of 90 tablets with dosage information provided in the accompanying insert. The tablets should be stored in a tightly closed, light-resistant container at 20° to 25°C (68° to 77°F). It is important to protect the tablets from moisture and keep them out of reach of children. The tablets are manufactured for Macleods Pharma USA, Inc., with manufacturing conducted by Macleods Pharmaceuticals Ltd in Badd, Himachal Pradesh, India.*

FDA Label Image

Fenofibrate-54-90-cont-daman (Fenofibrate 54 90 Cont Daman)

This text provides information on a medication called Fenofibrate, specifically Fenofibrate Tablets, USP with a strength of 54 mg. The product is manufactured by Macleods Pharma USA and should be stored in specific conditions to maintain its quality. It contains details on how to dispense and store the medication. The text also mentions the importance of keeping the medication out of reach of children and instructions not to use if the safety seal is broken or missing.*

FDA Label Image

Fenofibrate-54-9x14-daman-cart (Fenofibrate 54 9x14 Daman Cart)

This is a description of Fenofibrate tablets, each containing 54mg of the active ingredient. The tablets are part of a blister pack containing 126 tablets, with instructions to store them at a temperature range of 20 to 25 degrees Celsius. The packaging also includes information about the manufacturer, Macleods Pharma USA, and advises keeping the medication out of reach of children due to the packaging not being child-resistant. It is recommended to refer to the accompanying insert for complete prescribing information.*

FDA Label Image

Str (Fenofibrate Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.